Dr. Jorge Garcia, a committee member of the Oncologic Drugs Advisory Committee (ODAC), joins the Uromigos to discuss recent ODAC meetings on bladder cancer and the “dangling accelerated approvals” that resulted from those meetings.
Dr. Jorge Garcia, a committee member of the Oncologic Drugs Advisory Committee (ODAC), joins the Uromigos to discuss recent ODAC meetings on bladder cancer and the “dangling accelerated approvals” that resulted from those meetings.